Quoted Micro 26 January 2026

AQUIS STOCK EXCHANGE Cardiometabolic health products developer ProBiotix Health (PBX) increased sales by 45% to £2.72m in 2025 and reduced the loss. During the year, ProBiotix entered the Korean market and submitted applications for two new clinical trials. There was £1.27m in the bank at the end of £1.27m. The order book is worth £1.3m. […]

Quoted Micro 5 January 2026

AQUIS STOCK EXCHANGE Energy efficient technology developer Time to ACT (TTA) was held back by volatility of orders. In the six months to September 2025, revenues fell from £1.67m to £732,000, while the loss increased from £184,000 to £698,000. There are more than £4m of Large Parts contacts ready to be closed. In November 2025, […]

Andrew Hore – Quoted Micro 26 April 2021

AQUIS STOCK EXCHANGE Shepherd Neame (SHEP) in common with other brewers and pub companies has been hard hit by the closure of pubs. Monthly cash burn during pub closures is £1.5m-£2m. Unsurprisingly, interim revenues slumped from £79m to £55.3m, while an underlying pre-tax profit of £4.88m was turned into an underlying loss of £4.81m. Bottled […]

Andrew Hore – Quoted Micro 31 December 2018

NEX EXCHANGE  China-based Gamfook Jewellery (GAMF) joined NEX on 24 December. The online retailer of customised jewellery was introduced at 15p a share, and the shares ended the first week at 15.5p (14p/17p).  That values Gamfook at £15.5m. Executive chairman Jindian Lin and his wife own 72.8% of Gamfook. A dividend based on 28% of […]